Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Binds bacterium or component thereof or substance produced...
Reexamination Certificate
2009-10-19
2011-11-15
Swartz, Rodney P. (Department: 1645)
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Binds bacterium or component thereof or substance produced...
C424S009100, C424S009200, C424S130100, C424S164100, C424S184100, C424S234100, C424S248100, C435S004000, C435S007100, C435S007200, C435S007320, C435S007900, C435S007920
Reexamination Certificate
active
08057797
ABSTRACT:
The disclosed technology provides an enriched antibody population, highly specific for an antigen of a surface polysaccharide, from a mycobacterium. In a related embodiment, the antibody is enriched by having been raised in an environment that maintains antigenically active antigen. These antibodies may be used in an immunoreactive environment for detecting the presence of a mycobacterial infection in a sample from a subject.
REFERENCES:
patent: 5756327 (1998-05-01), Sassanfar et al.
patent: 6620785 (2003-09-01), Lambert, Jr.
patent: 7615222 (2009-11-01), Koulchin et al.
patent: 2002/0034763 (2002-03-01), Glatman-Freedman et al.
patent: 2002/0103118 (2002-08-01), Lambert, Jr.
patent: 2004/0038201 (2004-02-01), Nau et al.
patent: 2006/0127406 (2006-06-01), Koulchin et al.
patent: WO 92/14155 (1992-08-01), None
patent: WO 97/26007 (1997-07-01), None
patent: WO 97/34149 (1997-09-01), None
patent: WO 01/64237 (2001-09-01), None
patent: WO 2006/012413 (2006-02-01), None
patent: WO 2008/067497 (2008-06-01), None
Boggian, et al., “Infrequent Detection of Lipoarabinomannan Antibodies in Human Immunodeficiency Virus-Associated Mycobacterial Disease,”J. Clin. Micbiol., Swiss HIV Cohort Study., Jul. 1996, vol. 34, No. 7, pp. 1854-1855.
Lee, et al., “Mycobacterium tuberculosisCell Envelope,”Curr. Top Microbiol. Immunol., vol. 215, pp. 1-27.
Sada, et al., “Evaluation of Lipoarabinomannan for the Serological Diagnosis of Tuberculosis,”J. Clin. Microbiol., Dec. 1990, vol. 28, No. 12, pp. 2587-2590.
Ulrichs, et al., “Differential T Cell Responses toMycobacterium tuberculosisESAT6 in Tuberculosis Patients and Healthy Donors,” Eur. J. Immunol., vol. 28, 1998, pp. 3949-5958.
Doskeland, et al., “Bacterial Antigen Detection in Body Fluids: Methods for Rapid Antigen Concentration and Reduction of Nonspecific Reactions,”J. Clin. Microbiol., Apr. 1980, vol. 11, No. 4, pp. 380-384.
Hunter, et al., “Structure and Antigenicity of the Phosphorylated Lipopolysaccharide Antigens from the Leprosy andTubercle bacilli,” J. Biol. Chem., Sep. 15,1986, vol. 261, No. 26, pp. 12345-12351.
Britton, et al., “Separate Antigenic Determinants on Cell Wall Associated Carbohydrate Antigens ofMycobacterium IepraeDefined with Monoclonal Antibodies”International Journal of Leprosy and Other Mycobacterial Diseases, vol. 54, No. 4, Dec. 1986, pp. 545-555.
Levy, et al., “A Reevaluation of Sputum Microscopy and Culture in the Diagnosis of Pulmonary Tuberculosis,”Chest, Jun. 1989, vol. 95pp. 1193-1197.
Kramer, et al., “Delayed Diagnosis of Tuberculosis in Patients with Human Immunodeficiency Virus Infection,”Am. J. Med., Oct. 1990, vol. 89, pp. 451-456.
Chan, et al., “Lipoarabinomannan, a Possible Virulence Factor Involved in Persistence ofMycobacterium tuberculosisWithin Macrophages,”Infect. Immun., Mar. 1991, vol. 59, No. 5, pp. 1755-1761.
Sada, et al., “Detection of Lipoarabinomannan as a Diagnostic Test for Tuberculosis,”J. Clin Microbiol., Sep. 1992, vol. 30, No. 9, pp. 2415-2418.
International Searching Authority, International Search Report, International Application No. PCT/US92/01159, dated May 11, 1992, 2 pages.
Elliot, et al., “Negative Sputum Smear Results in HIV-Positive Patients With Pulmonary Tuberculosis in Lusaka, Zambia,”Tuber. Lung Dis., vol. 74, 1993, pp. 191-194.
Jones, et al., “Relationship of the Manifestations of Tuberculosis to CD4 cell counts in patients with Human Immunodeficiency Virus Infection,”Am. Rev. Respir. Dis.,vol. 148, 1993, pp. 1292-1297.
Githui, et al., “A Comparative Study on the Reliability of the Fluorescence Microscopy and Ziehl-Neelsen Method in the Diagnosis of Pulmonary Tuberculosis,”East Afr. Med. J., May 1993, vol. 70, No. 5, pp. 263-266.
Houston, et al., “The Association of Tuberculosis and HIV Infection in Harare, Zimbabwe,”Tuber. Lung Dis., vol. 75, 1994, pp. 220-226.
Noordhoek, et al., “Sensitivity and Specificity of PCR for Detection ofMycobacterium tuberculosis: Blind Comparison Study Among Seven Laboratories,”J. Clin. Microbiol., Feb. 1994, vol. 32, No. 2, pp. 277-284.
Bergmann, et al., “Clinical Evaluation of the Roche Amplicor PCRMycobacterium tuberculosisTest for Detection ofM. tuberculosisin Respiratory Specimens,”J. Clin Microbiol., May 1996, vol. 34, No. 5, pp. 1083-1085.
Zalipsky, et al., “Long-circulating, polyethylene glycol-grafted immunoliposomes”Journal of Controlled Release, Elsevier, Amsterdam, NL., May 1996, vol. 39, No. 2, pp. 153-161.
Young, et al., “Further characterization of a high molecular weight glycoprotein antigen from the yeastSaccharomyces cerevisiae” Carbohydrate Polymers, Applied Science Publishers, Ltd. Barking, GB, vol. 30, No. 4, Aug. 1, 1996, pp. 243-252.
Johnson, et al., “Impact of Human Immunodeficiency Virus Type-1 Infection on the Initial Bacteriologic and Radiographic Manifestations of Pulmonary Tuberculosis in Uganda,”Int. J. Tuberc. Lung Dis., 1997, pp. 397-404.
Ratanasuwan, et al., “Evaluation of the MycoDot Test for the Diagnosis of Tuberculosis in HIV Seropositive and Seronegative Patients,”Int. J. Tuberc. Lung Dis., 1997, vol. 1, No. 3, pp. 259-264.
International Searching Authority, International Search Report, International Application No. PCT/EP97/01037, dated Jul. 31, 1997, 3 pages.
Daffe, et al., “The Envelope Layers of Mycobacteria with Reference to their Pathogenicity,”Adv. Microb. Physiol., 1998, vol. 39, pp. 131-203.
Karstaedt, et al., “The Bacteriology of Pulmonary Tuberculosis in a Population with High Human Immunodeficiency Virus Seroprevalance,”Int. J. Tuberc. Lung Dis., 1998, vol. 2, No. 4, pp. 312-316.
Rajalahti, et al., “Detection ofMycobacterium tuberculosisComplex in Sputum Specimens by the Automated Roche Cobas AmplicorMycobacterium tuberculosisTest,”J. Clin Microbiol., vol. 36, No. 4, Apr. 1998, pp. 975-978.
Ravn, et al. “Human T Cell Responses to the ESAT-6 Antigen fromMycobacterium tuberculosis,” J. Infect. Dis., 1999, vol. 179, pp. 637-645.
Samb, et al., “Risk Factors for Negative Sputum Acid-Fast Bacilli Smears in Pulmonary Tuberculosis: Results from Dakar, Senegal, a City with Low HIV Seroprevalence.”Int. J. Tuberc. Lung Dis., 1999, vol. 3, No. 4, pp. 330-336.
Johnson, et al., “Tuberculin-Purified Protein Derivative-, MPT-64-, and ESAT-6- Stimulated Gamma Interferon Responses in Medical StudentS Before and AfterMycobacterium bovisBCG Vaccination and in Patients with Tuberculosis,”Clin. Diagn Lab Immunol, vol. 6, No. 6, Nov. 1999, pp. 934-937.
Swaminathan, et al., “Risk of Development of Tuberculosis in HIV-Infected Patients,”Int. J. Tuberc. Lung, 2000, vol. 4, No. 9, pp. 839-844.
Pereira, et al., “Development of Antigen Detection Assay for Diagnosis of Tuberculosis Using Sputum Samples,”J.Clin. Microbiol., vol. 38, No. 6, Jun. 2000, pp. 2278-2283.
Pottumarthy, et al., “A Comparison of Seven Tests for Serological Diagnosis of Tuberculosis,”J. Clin. Microbiol., vol. 38, No. 6, Jun. 2000, pp. 2227-2231.
Anderson, et al., “Specific Immune-Based Diagnosis of Tuberculosis,”The Lancet, vol. 356, Sep. 2000, pp. 1099-1104.
Hamasur, et al., “Rapid Diagnosis of Tuberculosis by Detection ofMycobacterial Lipoarabinomannanin Urine,”J. Microbiol. Methods, 2001, vol. 45, pp. 41-52.
Range, et al., “Trend in HIV Prevalence Among Tuberculosis Patients in Tanzania 1991-1998,”Int. J. Tuberc. Lung Dis., 2001, vol. 5, No. 5, pp. 405-412.
Tessema, et al., “Diagnostic Evaluation of Urinary Lipoarabinomannan at an Ethiopian Tuberculosis Centre,”Scan. J. Infect. Dis., 2001, vol. 33, No. 4, pp. 279-284 (Abstract).
Suh, et al., “Anti-JL1 antibody-conjugated poly (L-lysine) for targeted gene delivery to leukemia T cells”Journal of Controlled Release, Else
Kerrick Jill L.
Koulchin Vladimir A.
Molokova Elena V.
Chemogen, Inc.
Sunstein Kann Murphy & Timbers LLP
Swartz Rodney P.
LandOfFree
Method of preparing enriched antibodies for detecting... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of preparing enriched antibodies for detecting..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of preparing enriched antibodies for detecting... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4282082